348 Épisodes

  1. Renal Cell Carcinoma

    Publié: 04/11/2020
  2. Acute Myeloid Leukemia with FLT3 Mutations

    Publié: 30/10/2020
  3. Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

    Publié: 27/10/2020
  4. PARP Inhibition in the Management of Pancreatic Cancer

    Publié: 23/10/2020
  5. Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy

    Publié: 21/10/2020
  6. Front-Line Treatment of Chronic Lymphocytic Leukemia

    Publié: 13/10/2020
  7. Hodgkin Lymphoma

    Publié: 02/10/2020
  8. Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition

    Publié: 30/09/2020
  9. PARP Inhibitors in Breast Cancer Edition

    Publié: 23/09/2020
  10. Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition

    Publié: 21/09/2020
  11. Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition

    Publié: 17/09/2020
  12. Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition

    Publié: 15/09/2020
  13. Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition

    Publié: 11/09/2020
  14. Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition

    Publié: 04/09/2020
  15. Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition

    Publié: 28/08/2020
  16. Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard

    Publié: 18/08/2020
  17. Oncology Today Special Roundtable: Colorectal Cancer

    Publié: 05/08/2020
  18. Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson

    Publié: 01/08/2020
  19. Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer

    Publié: 17/06/2020
  20. Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2

    Publié: 05/06/2020

17 / 18

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Visit the podcast's native language site